Manufacturing Supplement Reviews Will Not Lag Under PDUFA, FDA Says

Manufacturing supplement resubmissions will not suffer from a lack of review goals under PDUFA, Center for Biologics Evaluation & Research Associate Director for Review Management Robert Yetter, PhD, maintained during the Biotechnology Industry Organization annual meeting June 12

More from Archive

More from Pink Sheet